Also trades as: 7733.T (JPX) · $vol 57M · OCPNY (OTC) · $vol 7M · OLYMY (OTC) · $vol 1M

$12.13

+0.00 (+0.00%)

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 45 · $13.4B mcap · 968M float · 0.0001% daily turnover · Short 81% of daily vol

Revenue

$1.02T +2.0% ▲

5Y CAGR: +6.8%

Gross Profit

$658.2B -3.7% ▼

5Y CAGR: +9.0%

Operating Income

$147.9B -8.9% ▼

5Y CAGR: +7.6%

Net Income

$68.6B -41.8% ▼

5Y CAGR: +39.6%

EPS (Diluted)

$62.31 -39.4% ▼

5Y CAGR: +4.1%

EBITDA

$215.6B -7.2% ▼

5Y CAGR: +6.0%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$868.9B	$881.9B	$936.2B	$997.3B	$1.02T
YoY Growth	+18.9%	+1.5%	+6.2%	+6.5%	+2.0%
Cost of Revenue	$274.1B	$319.2B	$311.1B	$313.6B	$358.8B
Gross Profit	$476.0B	$562.7B	$625.1B	$683.7B	$658.2B
Gross Margin	54.8%	63.8%	66.8%	68.6%	64.7%
R&D Expenses	$85.3B	$76.9B	$86.4B	$0	$110.6B
SG&A Expenses	$241.3B	$306.7B	$437.9B	$495.7B	$399.6B
Operating Expenses	$326.6B	$383.6B	$473.2B	$521.2B	$510.3B
Operating Income	$166.3B	$186.6B	$151.9B	$162.5B	$147.9B
Operating Margin	19.1%	21.2%	16.2%	16.3%	14.5%
Interest Expense	$5.8B	$8.2B	$10.3B	$6.8B	$9.4B
Income Before Tax	$149.9B	$181.8B	$35.9B	$159.1B	$94.6B
Tax Expense	$33.9B	$44.3B	$8.9B	$41.3B	$26.0B
Net Income	$115.7B	$143.4B	$242.6B	$117.9B	$68.6B
Net Margin	13.3%	16.3%	25.9%	11.8%	6.7%
EPS (Diluted)	$90.17	$108.65	$21.88	$102.80	$62.31
EBITDA	$233.2B	$238.8B	$112.1B	$232.4B	$215.6B
Shares Outstanding	1.28B	1.27B	1.22B	1.15B	1.11B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$234.8B	$239.2B	$251.2B	$272.1B	$206.5B	$247.8B	$261.3B	$297.1B
Cost of Revenue	$78.6B	$72.5B	$83.2B	$79.3B	$71.4B	$86.5B	$96.2B	$103.2B
Gross Profit	$156.2B	$166.8B	$168.0B	$192.8B	$135.1B	$161.3B	$165.0B	$194.0B
Gross Margin	66.5%	69.7%	66.9%	70.8%	65.4%	65.1%	63.2%	65.3%
R&D Expenses	$0	$0	$0	$103.9B	$194M	$181M	$25.9B	$29.6B
SG&A Expenses	$118.8B	$119.1B	$125.1B	$132.6B	$122.2B	$119.9B	$99.9B	$110.6B
Operating Expenses	$128.7B	$123.7B	$129.7B	$139.1B	$118.5B	$131.8B	$125.8B	$140.2B
Operating Income	$27.5B	$43.1B	$38.3B	$53.7B	$16.6B	$29.5B	$39.3B	$53.8B
Operating Margin	11.7%	18.0%	15.2%	19.7%	8.0%	11.9%	15.0%	18.1%
Interest Expense	$2.2B	$1.4B	$1.9B	$4M	$8M	$5.3B	$2.3B	$519M
Income Before Tax	$26.4B	$42.4B	$36.4B	$53.9B	$16.9B	$27.9B	$22.2B	$27.2B
Tax Expense	$11.6B	$7.9B	$9.3B	$12.4B	$7.9B	$7.7B	$8.0B	$2.3B
Net Income	$14.6B	$34.4B	$27.4B	$41.5B	$9.0B	$20.2B	$14.2B	$25.0B
Net Margin	6.2%	14.4%	10.9%	15.2%	4.4%	8.1%	5.4%	8.4%
EPS (Diluted)	$12.66	$29.77	$23.93	$36.67	$7.96	$18.05	$12.85	$22.37
EBITDA	$44.8B	$59.7B	$54.9B	$71.8B	$32.6B	$50.2B	$57.0B	$70.4B
Shares Outstanding	1.17B	1.16B	1.13B	1.13B	1.13B	1.12B	1.10B	1.11B

OCPNF OTC